Skip to main content
Livermore
Livermore
ZHEN

Baker Bros. Advisors LP

SEC CIK
0001263508
Latest filing
Aug 14, 2026

VERV holding history

Verve Therapeutics, Inc. in every 13F filed by Baker Bros. Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VERV overviewAll 13F holders of VERVFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
17
Since Q2 2021
Holdings of VERV by Baker Bros. Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−1,691,530−100.0%Sold outHolders
Q2 20251,691,530$19.0M0.2%00.0%UnchangedHolders
Q1 20251,691,530$7.73M0.1%00.0%UnchangedHolders
Q4 20241,691,530$9.54M0.1%00.0%UnchangedHolders
Q3 20241,691,530$8.19M0.1%00.0%UnchangedHolders
Q2 20241,691,530$8.25M0.1%00.0%UnchangedHolders
Q1 20241,691,530$22.5M0.3%00.0%UnchangedHolders
Q4 20231,691,530$23.6M0.3%+275,000+19.4%AddedHolders
Q3 20231,416,530$18.8M0.1%00.0%UnchangedHolders
Q2 20231,416,530$26.6M0.2%00.0%UnchangedHolders
Q1 20231,416,530$20.4M0.1%00.0%UnchangedHolders
Q4 20221,416,530$27.4M0.2%00.0%UnchangedHolders
Q3 20221,416,530$48.7M0.3%00.0%UnchangedHolders
Q2 20221,416,530$21.6M0.1%00.0%UnchangedHolders
Q1 20221,416,530$32.3M0.2%00.0%UnchangedHolders
Q4 20211,416,530$52.2M0.3%00.0%UnchangedHolders
Q3 20211,416,530$66.6M0.3%00.0%UnchangedHolders
Q2 20211,416,530$85.3M0.4%+1,416,530NewHolders